Author
University of VermontORCID 0000-0001-8762-5422Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Kathleen S Metz Reed, Andrew J. Fritz, Haley W. Greenyer…·Tom Misteli
The paper profiles genome organization changes during breast cancer progression using Micro-C mapping and links these changes to gene expression and enhancer activity.
Emory Pacht, Janine S. A. Warren, Rabail Hassan Toor…·Janet Lee Stein
The paper identifies MANCR isoforms' roles in epigenomic and P53-responsive transcriptional control in TNBC through computational and experimental methods.
Andrew J. Fritz, Haley W. Greenyer, Louis Dillac…·Gary S. Stein
This study shows that acute RUNX1 loss reprograms enhancer activity, leading to epithelial destabilization and cancer hallmark activation in human mammary epithelial cells.
Hana Paculová, Alyssa R. Richman, Joseph Boyd…·Seth E. Frietze
This study identifies ERG as a vulnerability in IKZF1-mutated B-cell acute lymphoblastic leukemia through gene regulatory network analysis and functional validation.
Margaret Phillips, Hassan Zafar, Matthew R. Marunde…·Karen C. Glass
This paper investigates the binding specificity of CECR2-BRD to acetylated histone and non-histone ligands, revealing distinct binding modes and functional roles in chromatin regulation and inflammation.
Deli Hong, Andrew J. Fritz, Kristiaan H. Finstad…·Gary S. Stein
This study shows that Runx1 suppresses breast cancer stemness and tumor growth by inhibiting Zeb1 and epithelial-mesenchymal transition.